Sullivan, Bruyette, Speros & Blaney’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$332K Hold
4,208
0.01% 227
2020
Q4
$360K Buy
4,208
+166
+4% +$13.7K 0.02% 199
2020
Q3
$312K Sell
4,042
-1,181
-23% -$90K 0.02% 194
2020
Q2
$383K Sell
5,223
-18
-0.3% -$1.28K 0.02% 160
2020
Q1
$348K Hold
5,241
0.02% 151
2019
Q4
$361K Hold
5,241
0.02% 170
2019
Q3
$385K Sell
5,241
-606
-10% -$44K 0.02% 157
2019
Q2
$419K Sell
5,847
-197
-3% -$14K 0.03% 145
2019
Q1
$414K Buy
6,044
+973
+19% +$62.8K 0.03% 136
2018
Q4
$302K Hold
5,071
0.02% 152
2018
Q3
$340K Buy
5,071
+3
+0.1% +$200 0.03% 124
2018
Q2
$328K Sell
5,068
-510
-9% -$33.4K 0.03% 126
2018
Q1
$400K Buy
5,578
+5
+0.1% +$360 0.04% 103
2017
Q4
$420K Buy
5,573
+6
+0.1% +$438 0.04% 103
2017
Q3
$406K Buy
5,567
+427
+8% +$30.8K 0.04% 101
2017
Q2
$381K Sell
5,140
-645
-11% -$47.9K 0.04% 104
2017
Q1
$423K Buy
5,785
+656
+13% +$45.9K 0.04% 88
2016
Q4
$336K Buy
5,129
+2
+0% +$137 0.03% 104
2016
Q3
$380K Buy
5,127
+15
+0.3% +$1.11K 0.04% 90
2016
Q2
$374K Buy
+5,112
New +$364K 0.04% 90

Other funds holding CL

Sullivan, Bruyette, Speros & Blaney's CL Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney held its Colgate-Palmolive (CL) position steady in Q1 2021 at 4,208 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #227.

Sullivan, Bruyette, Speros & Blaney first reported a position in CL in Q2 2016 and has held it in 20 quarters since. The position peaked at $423K in Q1 2017. 1,608 funds tracked by Wall St. Rank hold CL as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 4,208 shares of Colgate-Palmolive worth $332K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney left its Colgate-Palmolive share count unchanged in Q1 2021.
  • Colgate-Palmolive made up 0.01% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #227 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Colgate-Palmolive in Q2 2016 and has held it in 20 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Colgate-Palmolive position peaked at $423K in Q1 2017.
  • 1,608 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.